A SIMPLE RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF ORGANIC IMPURITIES, ENANTIOMER AND ASSAY OF DEXLANSOPRAZOLE

Objective: To develop a simple and accurate RP-HPLC method for simultaneous estimation of organic impurities, enantiomer and assay of Dexlansoprazole, proposed method was validated according to an International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH) guidelines. Methods: Cellulose tris -(3,5-dichlorophenylcarbamate) bonded on silica gel (Chiralpak IC) were used as stationary phase. Acetonitrile (ACN) and 10 mM dibasic potassium phosphate buffer of pH 7.20, adjusted with dilute ortho phosphoric acid, were used as mobile phase in gradient composition at a flow rate of 1.0 ml/min. UV detection was made at 283 nm and run time was 27 min. Results: Limit of detection (LOD) and Limit of quantification (LOQ) was 42 and 126 ng/ml, respectively. Analytes response was studied from 0.25-1.50 µg/ml and r 2 value of the calibration curve was>0.999. Accuracy was studied in three different concentrations, the mean recovery was observed between 93.8 and 102.5%. To the maximum of 0.01% impurity variation was observed between the results of inter and intra-day precision. Conclusion: Proposed method is specific, precise, sensitive, linear and accurate. As a significance of this proposed method, the listed known impurities of Lansoprazole monograph [United States, British and European pharmacopoeias (USP/BP/Ph. Eur.)] Were used in method development and separation was demonstrated. Apart from this, enantiomer resolution was achieved and the same chromatogram was used for assay calculation.

[1]  R. Bhushan,et al.  Normal and polar-organic-phase high-performance liquid chromatographic enantioresolution of omeprazole, rabeprazole, lansoprazole and pantoprazole using monochloro-methylated cellulose-based chiral stationary phase and determination of dexrabeprazole. , 2014, Biomedical chromatography : BMC.

[2]  S. Duvvuri,et al.  Enantiomeric separation of proton pump inhibitors on new generation chiral columns using LC and supercritical fluid chromatography. , 2013, Journal of separation science.

[3]  R. Cirilli,et al.  Retention behavior of proton pump inhibitors using immobilized polysaccharide-derived chiral stationary phases with organic-aqueous mobile phases. , 2013, Journal of chromatography. A.

[4]  Lishuang Xu,et al.  A validated, specific, stability-indicating HPLC method for determination of lansoprazole enteric capsules and related impurities , 2012 .

[5]  W. J. Lough,et al.  Assessment of chiral stationary phases for suitability for combined enantiomeric impurity/related substances assays. , 2011, Journal of chromatography. A.

[6]  T. Farkas,et al.  Reversed-phase chiral HPLC and LC/MS analysis with tris(chloromethylphenylcarbamate) derivatives of cellulose and amylose as chiral stationary phases. , 2010, Journal of chromatography. A.

[7]  R. Cirilli,et al.  Direct HPLC enantioseparation of omeprazole and its chiral impurities: application to the determination of enantiomeric purity of esomeprazole magnesium trihydrate. , 2010, Journal of pharmaceutical and biomedical analysis.

[8]  Tong Zhang,et al.  Reversed-phase screening strategies for liquid chromatography on polysaccharide-derived chiral stationary phases. , 2010, Journal of chromatography. A.

[9]  R. Cirilli,et al.  Development and validation of an enantioselective and chemoselective HPLC method using a Chiralpak IA column to simultaneously quantify (R)-(+)- and (S)-(-)-lansoprazole enantiomers and related impurities. , 2009, Journal of pharmaceutical and biomedical analysis.

[10]  A. Wen,et al.  Simultaneous determination of lansoprazole and its metabolites 5'-hydroxy lansoprazole and lansoprazole sulphone in human plasma by LC-MS/MS: application to a pharmacokinetic study in healthy volunteers. , 2008, Journal of pharmaceutical and biomedical analysis.

[11]  T. Hishinuma,et al.  Simple quantification of lansoprazole and rabeprazole concentrations in human serum by liquid chromatography/tandem mass spectrometry. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[12]  Tong Zhang,et al.  Enantiomer resolution screening strategy using multiple immobilised polysaccharide-based chiral stationary phases. , 2008, Journal of chromatography. A.

[13]  Q. Cass,et al.  Multimilligram enantioresolution of sulfoxide proton pump inhibitors by liquid chromatography on polysaccharide-based chiral stationary phase. , 2008, Journal of pharmaceutical and biomedical analysis.

[14]  T. Habuchi,et al.  Determination of rabeprazole enantiomers and their metabolites by high-performance liquid chromatography with solid-phase extraction. , 2006, Journal of pharmaceutical and biomedical analysis.

[15]  M. Miura,et al.  Simultaneous determination of lansoprazole enantiomers and their metabolites in plasma by liquid chromatography with solid-phase extraction. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[16]  T. Andersson Single-Isomer Drugs , 2004, Clinical pharmacokinetics.

[17]  L. T. Taylor,et al.  Demonstrative validation study employing a packed column pressurized fluid chromatography method that provides assay, achiral impurities, chiral impurity, and IR identity testing for a drug substance. , 2001, Journal of pharmaceutical and biomedical analysis.